Skip to main content

Advertisement

Log in

Health-related quality of life in patients with systemic lupus erythematosus: a Spanish study based on patient reports

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Introduction and objectives

Systemic lupus erythematosus (SLE) is a disease that significantly affects the quality of life and welfare of patients. SLE patients can be classified into multimorbidity levels using Clinical Risk Groups (CRGs) to help to incorporate predictive models of health needs. The goal of this study was to correlate CRGs with health-related quality of life (HR-QoL) and costs in SLE patients.

Methods

A questionnaire was administered to SLE patients in four hospital centers of the Valencian Community (Spain) between October 2015 and March 2016. The factors studied included HR-QoL (EQ-5D-5L and VAS), disease activity (SLAI/SELENA), damage (SLICC/ACR), and severity (IGK).

Results

The patients (N = 190, 92.06% female, age (mean ± SD) 47.23 ± 13.43 years) were sorted according to health status in nine CRGs. We found that most SLE patients (> 70%) were in CRGs 5 and 6. The main HR-QoL issues in these patients were related to mobility, ability to perform usual activities, and pain/discomfort. The scores (mean ± SD) for EQ-5D-5L and VAS were 0.74 ± 0.25 and 65.67 ± 23.52, respectively. We found that the age of the patients negatively affected their HR-QoL (r = − 0.266). SLE direct costs per patient increased with each CRG group, representing 71.92% of the total costs, while indirect costs were highly variable. The average cost per patient with SLE amounted to €8432.85 (year 2014).

Conclusions

Patients’ quality of life is related with age, disease activity, damage, and severity. Age was the parameter which most affects HR-QoL. Most costs of SLE are concentrated in two CRGs in which the HR-QoL deteriorates sharply.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Kaul A, Gordon C, Crow MK, Touma Z, Urowitz MB, van Vollenhoven R, Ruiz-Irastorza G, Hughes G (2016) Systemic lupus erythematosus. Nat Rev Dis Prim 2:16039. https://doi.org/10.1038/nrdp.2016.39

    Article  PubMed  Google Scholar 

  2. Cervera R, Doria A, Amoura Z, Khamashta M, Schneider M, Guillemin F, Maurel F, Garofano A, Roset M, Perna A, Murray M, Schmitt C, Boucot I (2014) Patterns of systemic lupus erythematosus expression in Europe. Autoimmun Rev 13:621–629

    Article  CAS  PubMed  Google Scholar 

  3. Seoane-Mato D, Sánchez-Piedra C, Díaz-González F, Bustabad S (2018) Prevalence of rheumatic diseases in the adult population in Spain. EPISER 2016 study. Ann Rheum Dis 77:535–536

    Google Scholar 

  4. Cervera R, Rúa-Figueroa I, Gil-Aguado A, Sabio JM, Pallarés L, Hernández-Pastor LJ, Iglesias M (2013) Direct cost of management and treatment of active systemic lupus erythematosus and its flares in Spain: the LUCIE study. Rev Clínica Española 213:127–137. https://doi.org/10.1016/j.rce.2012.11.018

    Article  CAS  Google Scholar 

  5. Chambers SA, Allen E, Rahman A, Isenberg D (2009) Damage and mortality in a group of British patients with systemic lupus erythematosus followed up for over 10 years. Rheumatology 48:673–675. https://doi.org/10.1093/rheumatology/kep062

    Article  PubMed  Google Scholar 

  6. Golder V, Hoi A (2017) Systemic lupus erythematosus: an update. Med J Aust 206:215–220. https://doi.org/10.5694/mja16.01229

    Article  PubMed  Google Scholar 

  7. Waldheim E, Ajeganova S, Bergman S, Frostegård J, Welin E (2018) Variation in pain related to systemic lupus erythematosus (SLE): a 7-year follow-up study. Clin Rheumatol 37:1825–1834. https://doi.org/10.1007/s10067-018-4079-1

    Article  PubMed  PubMed Central  Google Scholar 

  8. Bexelius C, Wachtmeister K, Skare P, Jönsson L, Vollenhoven R (2013) Drivers of cost and health-related quality of life in patients with systemic lupus erythematosus (SLE): a Swedish nationwide study based on patient reports. Lupus 22:793–801. https://doi.org/10.1177/0961203313491849

    Article  CAS  PubMed  Google Scholar 

  9. Holloway L, Humphrey L, Heron L, Pilling C, Kitchen H, Højbjerre L, Strandberg-Larsen M, Hansen BB (2014) Patient-reported outcome measures for systemic lupus erythematosus clinical trials: a review of content validity, face validity and psychometric performance. Health Qual Life Outcomes 12:116. https://doi.org/10.1186/s12955-014-0116-1

    Article  PubMed  PubMed Central  Google Scholar 

  10. Jolly M, Pickard AS, Block JA, Kumar RB, Mikolaitis RA, Wilke CT, Rodby RA, Fogg L, Sequeira W, Utset TO, Cash TF, Moldovan I, Katsaros E, Nicassio P, Ishimori ML, Kosinsky M, Merrill JT, Weisman MH, Wallace DJ (2012) Disease-specific patient reported outcome tools for systemic lupus erythematosus. YSARH 42:56–65. https://doi.org/10.1016/j.semarthrit.2011.12.005

    Article  Google Scholar 

  11. Doward LC, McKenna SP, Whalley D et al (2009) The development of the L-QoL: a quality-of-life instrument specific to systemic lupus erythematosus. Ann Rheum Dis 68:196–200. https://doi.org/10.1136/ard.2007.086009

    Article  CAS  PubMed  Google Scholar 

  12. Yazdany J (2011) Health-related quality of life measurement in adult systemic lupus erythematosus: Lupus Quality of Life (LupusQoL), Systemic Lupus Erythematosus-Specific Quality of Life Questionnaire (SLEQOL), and Systemic Lupus Erythematosus Quality of Life Questionnaire. Arthritis Care Res (Hoboken) 63:S413–S419. https://doi.org/10.1002/acr.20636

    Article  Google Scholar 

  13. Cho JH, Chang SH, Shin NH, Choi BY, Oh HJ, Yoon MJ, Lee EY, Lee EB, Lee TJ, Song YW (2014) Costs of illness and quality of life in patients with systemic lupus erythematosus in South Korea. Lupus 23:949–957. https://doi.org/10.1177/0961203314524849

    Article  CAS  PubMed  Google Scholar 

  14. Jones JT, Cunningham N, Kashikar-Zuck S, Brunner HI (2016) Pain, fatigue, and psychological impact on health-related quality of life in childhood-onset lupus. Arthritis Care Res 68:73–80. https://doi.org/10.1002/acr.22650

    Article  Google Scholar 

  15. Schmeding A, Schneider M (2013) Fatigue, health-related quality of life and other patient-reported outcomes in systemic lupus erythematosus. Best Pract Res Clin Rheumatol 27:363–375. https://doi.org/10.1016/j.berh.2013.07.009

    Article  CAS  PubMed  Google Scholar 

  16. Roche PA, Klestov AC, Heim HM (2003) Description of stable pain in rheumatoid arthritis: a 6-year study. J Rheumatol 30:1733–1738

    PubMed  Google Scholar 

  17. Katz JD, Senecal JL, Rivest C et al (1993) A simple severity of disease index for systemic lupus erythematosus. Lupus 2:119–123. https://doi.org/10.1177/096120339300200210

    Article  CAS  PubMed  Google Scholar 

  18. Hughes J, Verill R, Eisenhandler J et al (2004) Clinical risk groups (CRGs): a classification system for risk-adjusted capitation-based payment and health care management. Med Care 42:81–90

    Article  PubMed  Google Scholar 

  19. Vivas-Consuelo D, Usó-Talamantes R, Guadalajara-Olmeda N, Trillo-Mata JL, Sancho-Mestre C, Buigues-Pastor L (2014) Pharmaceutical cost management in an ambulatory setting using a risk adjustment tool. BMC Health Serv Res 14:462. https://doi.org/10.1186/1472-6963-14-462

    Article  PubMed  PubMed Central  Google Scholar 

  20. EuroQol Group (1990) EuroQol—a new facility for the measurement of health-related quality of life. Health Policy:10109801

  21. EuroQol Research (2015) EQ-5D-5L user guide. Basic Inf how to use EQ-5D-5L Instrum 28. doi: 1–25

  22. Isenberg DA, Allen E, Farewell V, D'Cruz D, Alarcon GS, Aranow C, Bruce IN, Dooley MA, Fortin PR, Ginzler EM, Gladman DD, Hanly JG, Inanc M, Kalunian K, Khamashta M, Merrill JT, Nived O, Petri M, Ramsey-Goldman R, Sturfelt G, Urowitz M, Wallace DJ, Gordon C, Rahman A (2011) An assessment of disease flare in patients with systemic lupus erythematosus: a comparison of BILAG 2004 and the flare version of SELENA. Ann Rheum Dis 70:54–59. https://doi.org/10.1136/ard.2010.132068

    Article  CAS  PubMed  Google Scholar 

  23. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH, Austin A, Bell A, Bloch DA, Corey PN, Decker JL, Esdaile J, Fries JF, Ginzler EM, Goldsmith CH, Hochberg MC, Jones JV, Riche NGHL, Liang MH, Lockshin MD, Muenz LR, Sackett DL, Schur PH (1992) Derivation of the sledai. A disease activity index for lupus patients. Arthritis Rheum 35:630–640. https://doi.org/10.1002/art.1780350606

    Article  CAS  PubMed  Google Scholar 

  24. Gladman DD, Goldsmith CH, Urowitz MB, Bacon P, Fortin P, Ginzler E, Gordon C, Hanly JG, Isenberg DA, Petri M, Nived O, Snaith M, Sturfelt G (2000) The Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) Damage Index for systemic lupus erythematosus international comparison. J Rheumatol 27:373–376

    CAS  PubMed  Google Scholar 

  25. Lai JS, Beaumont JL, Jensen SE, Kaiser K, van Brunt DL, Kao AH, Chen SY (2017) An evaluation of health-related quality of life in patients with systemic lupus erythematosus using PROMIS and Neuro-QoL. Clin Rheumatol 36:555–562. https://doi.org/10.1007/s10067-016-3476-6

    Article  PubMed  Google Scholar 

  26. Aggarwal R, Wilke CT, Pickard AS et al (2009) Psychometric properties of the EuroQol-5D and short form-6D in patients with systemic lupus erythematosus. J Rheumatol 36:1209–1216. https://doi.org/10.3899/jrheum.081022

    Article  PubMed  Google Scholar 

  27. Carreras M, Ibern P, Coderch J, Sánchez I, Inoriza JM (2013) Estimating lifetime healthcare costs with morbidity data. BMC Health Serv Res 13:440. https://doi.org/10.1186/1472-6963-13-440

    Article  PubMed  PubMed Central  Google Scholar 

  28. Doria A, Amoura Z, Cervera R, Khamastha MA, Schneider M, Richter J, Guillemin F, Kobelt G, Maurel F, Garofano A, Perna A, Murray M, Schmitt C, Boucot I (2014) Annual direct medical cost of active systemic lupus erythematosus in five European countries. Ann Rheum Dis 73:154–160. https://doi.org/10.1136/annrheumdis-2012-202443

    Article  PubMed  Google Scholar 

  29. Khamashta MA, Bruce IN, Gordon C, Isenberg DA, Ateka-Barrutia O, Gayed M, Donatti C, Guillermin AL, Foo J, Perna A (2014) The cost of care of systemic lupus erythematosus (SLE) in the UK: annual direct costs for adult SLE patients with active autoantibody-positive disease. Lupus 23:273–283. https://doi.org/10.1177/0961203313517407

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The authors thank Francisco López de Saro (Trialance SCCL) for medical writing support.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to D. Vivas-Consuelo.

Ethics declarations

Conflict of interest

The authors declare they have no conflicts of interest.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Román Ivorra, J.A., Fernández-Llanio-Comella, N., San-Martín-Álvarez, A. et al. Health-related quality of life in patients with systemic lupus erythematosus: a Spanish study based on patient reports. Clin Rheumatol 38, 1857–1864 (2019). https://doi.org/10.1007/s10067-019-04485-6

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-019-04485-6

Keywords

Navigation